The global Alzheimer’s drugs market is entering a crucial decade shaped by rising disease awareness, rapid advancements in diagnostic technologies, and increased government funding for neurological research. Valued at US$ 4.0 Bn in 2023, the market is projected to grow at a robust 10.0% CAGR between 2024 and 2034, reaching US$ 11.6 Bn by the end of the forecast period. As the global aging...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek